|
1
|
Ambros V: MicroRNA pathways in flies and
worms: growth, death, fat, stress, and timing. Cell. 113:673–676.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bartel DP: MicroRNAs: target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Griffiths-Jones S, Grocock RJ, van Dongen
S, Bateman A and Enright AJ: miRBase: microRNA sequences, targets
and gene nomenclature. Nucleic Acids Res. 34:D140–D144. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
He L, Thomson JM, Hemann MT, et al: A
microRNA polycistron as a potential human oncogene. Nature.
435:828–833. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tam W and Dahlberg JE: miR-155/BIC as an
oncogenic microRNA. Genes Chromosomes Cancer. 45:211–212. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Papagiannakopoulos T, Shapiro A and Kosik
KS: MicroRNA-21 targets a network of key tumor-suppressive pathways
in glioblastoma cells. Cancer Res. 68:8164–8172. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hammond SM: MicroRNAs as tumor
suppressors. Nat Genet. 39:582–583. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tazawa H, Tsuchiya N, Izumiya M and
Nakagama H: Tumor-suppressive miR-34a induces senescence-like
growth arrest through modulation of the E2F pathway in human colon
cancer cells. Proc Natl Acad Sci USA. 104:15472–15477. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yanaihara N, Caplen N, Bowman E, et al:
Unique microRNA molecular profiles in lung cancer diagnosis and
prognosis. Cancer Cell. 9:189–198. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mattie MD, Benz CC, Bowers J, et al:
Optimized high-throughput microRNA expression profiling provides
novel biomarker assessment of clinical prostate and breast cancer
biopsies. Mol Cancer. 5:242006. View Article : Google Scholar
|
|
11
|
Chen Y and Stallings RL: Differential
patterns of microRNA expression in neuroblastoma are correlated
with prognosis, differentiation, and apoptosis. Cancer Res.
67:976–983. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ru Y, Dancik GM and Theodorescu D:
Biomarkers for prognosis and treatment selection in advanced
bladder cancer patients. Curr Opin Urol. 21:420–427. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Eis PS, Tam W, Sun L, et al: Accumulation
of miR-155 and BIC RNA in human B cell lymphomas. Proc Natl Acad
Sci USA. 102:3627–3632. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wald AI, Hoskins EE, Wells SI, Ferris RL
and Khan SA: Alteration of microRNA profiles in squamous cell
carcinoma of the head and neck cell lines by human papillomavirus.
Head Neck. 33:504–512. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kong W, He L, Coppola M, Guo J, Esposito
NN, Coppola D and Cheng JQ: MicroRNA-155 regulates cell survival,
growth, and chemosensitivity by targeting FOXO3a in breast cancer.
J Biol Chem. 285:17869–17879. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Volinia S, Calin GA, Liu CG, et al: A
microRNA expression signature of human solid tumors defines cancer
gene targets. Proc Natl Acad Sci USA. 103:2257–2261. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Juan D, Alexe G, Antes T, et al:
Identification of a microRNA panel for clear-cell kidney cancer.
Urology. 75:835–841. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Du ZM, Hu LF, Wang HY, Yan LX, Zeng YX,
Shao JY and Ernberg I: Upregulation of MiR-155 in nasopharyngeal
carcinoma is partly driven by LMP1 and LMP2A and downregulates a
negative prognostic marker JMJD1A. PLoS One. 6:e191372011.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bundred NJ: Prognostic and predictive
factors in breast cancer. Cancer Treat Rev. 27:137–142. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Devi KR, Kuruvila S and Musa MM:
Pathological prognostic factors in breast carcinoma. Saudi Med J.
21:372–375. 2000.PubMed/NCBI
|
|
21
|
Wiseman SM, Makretsov N, Nielsen TO, et
al: Coexpression of the type 1 growth factor receptor family
members HER-1, HER-2, and HER-3 has a synergistic negative
prognostic effect on breast carcinoma survival. Cancer.
103:1770–1777. 2005. View Article : Google Scholar
|
|
22
|
Singletary SE, Allred C, Ashley P, et al:
Staging system for breast cancer: revisions for the 6th edition of
the AJCC Cancer Staging Manual. Surg Clin North Am. 83:803–819.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang RG, Zhang RP, Wang XW and Xie H:
Effects of cisplatin on telomerase activity and telomere length in
BEL-7404 humanhepatoma cells. Cell Res. 12:55–62. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
O’Connell RM, Taganov KD and Boldin MP:
MicroRNA-155 is induced during the macrophage inflammatory
response. Proc Natl Acad Sci USA. 104:1604–1609. 2007.PubMed/NCBI
|
|
25
|
O’Connell RM, Kahn D, Gibson WS, et al:
MicroRNA-155 promotes autoimmune inflammation by enhancing
inflammatory T cell development. Immunity. 33:607–619. 2010.
|
|
26
|
Bhattacharyya S, Balakathiresan NS,
Dalgard C, et al: Elevated miR-155 promotes inflammation in cystic
fibrosis by driving hyperexpression of interleukin-8. J Biol Chem.
286:11604–11615. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
O’Connell RM, Rao DS, Chaudhuri AA, et al:
Sustained expression of microRNA-155 in hematopoietic stem cells
causes a myeloproliferative disorder. J Exp Med. 205:585–594.
2008.PubMed/NCBI
|
|
28
|
Urbich C, Kuehbacher A and Dimmeler S:
Role of microRNAs in vascular diseases, inflammation, and
angiogenesis. Cardiovasc Res. 79:581–588. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jiang S, Zhang HW, Lu MH, et al:
MicroRNA-155 functions as an OncomiR in breast cancer by targeting
the suppressor of cytokine signaling 1 gene. Cancer Res.
70:3119–3127. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Pedersen IM, Otero D, Kao E, Miletic AV,
et al: Onco-miR-155 targets SHIP1 to promote TNFalpha-dependent
growth of B cell lymphomas. EMBO Mol Med. 1:288–295. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tili E, Croce CM and Michaille JJ:
miR-155: on the crosstalk between inflammation and cancer. Int Rev
Immunol. 28:264–284. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Iorio MV, Ferracin M, Liu CG, et al:
MicroRNA gene expression deregulation in human breast cancer.
Cancer Res. 65:7065–7070. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wrba F, Reiner A, Markis-Ritzinger E,
Holzner JH, Reiner G and Spona J: Prognostic significance of
immunohistochemical parameters in breast carcinomas. Pathol Res
Pract. 183:277–283. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Carter CL, Allen C and Henson DE: Relation
of tumor size, lymph node status, and survival in 24,740 breast
cancer cases. Cancer. 63:181–187. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
De Azambuja E, Cardoso F, de Castro G Jr,
et al: Ki-67 as prognostic marker in early breast cancer: a
meta-analysis of published studies involving 12,155 patients. Br J
Cancer. 96:1504–1513. 2007.PubMed/NCBI
|
|
36
|
Zhu W, Qin W, Atasoy U and Sauter ER:
Circulating microRNAs in breast cancer and healthy subjects. BMC
Res Notes. 2:892009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lu J and Tsourkas A: Imaging individual
microRNAs in single mammalian cells in situ. Nucleic Acids Res.
37:e1002009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lee YT and Markland FS: Steroid receptors
study in breast carcinoma. Med Pediatr Oncol. 5:153–166. 1978.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Paone JF, Abeloff MD, Ettinger DS, Arnold
EA and Baker RR: The correlation of estrogen and progesterone
receptor levels with response to chemotherapy for advanced
carcinoma of the breast. Surg Gynecol Obstet. 152:70–74.
1981.PubMed/NCBI
|
|
40
|
Clark GM and McGuire WL: Prognostic
factors in primary breast cancer. Breast Cancer Res Treat.
3(Suppl): S69–S72. 1983. View Article : Google Scholar
|
|
41
|
Linnstaedt SD, Gottwein E, Skalsky RL,
Luftig MA and Cullen BR: Virally induced cellular microRNA miR-155
plays a key role in B-cell immortalization by Epstein-Barr virus. J
Virol. 84:11670–11678. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Qin A, Zhou Y, Sheng M, Fei G, Ren T and
Xu L: Effects of microRNA-155 on the growth of human lung cancer
cell line 95D in vitro. Zhongguo Fei Ai Za Zhi. 14:575–580.
2011.PubMed/NCBI
|
